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Senescent cells provide a good in vitro model to study ageing. However,
cultures of ‘senescent’ cells consist of a mix of cell subtypes (proliferative,
senescent, growth-arrested and apoptotic). Determining the proportion
of senescent cells is crucial for studying ageing and developing new anti-
degenerative therapies. Commonly used markers such as doubling
population, senescence-associated β-galactosidase, Ki-67, γH2AX and
TUNEL assays capture diverse and overlapping cellular populations and
are not purely specific to senescence. A newly developed dynamical systems
model follows the transition of an initial culture to senescence tracking
population doubling, and the proportion of cells in proliferating, growth-
arrested, apoptotic and senescent states. Our model provides a parsimonious
description of transitions between these states accruing towards a predomi-
nantly senescent population. Using a genetic algorithm, these model
parameters are well constrained by an in vitro human primary fibroblast
dataset recording five markers at 16 time points. The computational model
accurately fits to the data and translates these joint markers into the first
complete description of the proportion of cells in different states over the
lifetime. The high temporal resolution of the dataset demonstrates the effi-
cacy of strategies for reconstructing the trajectory towards replicative
senescence with a minimal number of experimental recordings.1. Introduction
Ageing is a critical economic, social and medical challenge and understanding
the underlying molecular mechanisms is becoming increasingly important.
A major driver of ageing phenotypes in man and other species is the accumu-
lation of a population of terminally growth-arrested but metabolically active
cells termed senescent cells [1]. Gradual accumulation of senescent cells over
the life-course contributes to tissue degeneration and age-related disease [2,3].
Over the past few years, removal of senescent cells has been demonstrated not
only to delay the onset of age-related disorders [4] but also to bring about
improvements in phenotypes as diverse as osteoarthritis [5], cognitive function
[6] renal function [7], hepatic steatosis [8], metabolic function and adipogenesis
[9] and vasomotor dysfunction [10]. Besides the cell cycle arrest, senescent cells
show morphological, biochemical and functional changes such as secretion of
the senescence-associated secretory phenotype (SASP) and high levels of DNA
damage [11,12]. Accordingly, systems to remove or ameliorate the effects of
senescent cells are currently the subject of intensive study.
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2Senescent fibroblasts generated by continuous culture
until growth arrest (replicative senescence) provide a good
model to study ageing and age-related disease, exhibiting
many of the established hallmarks of ageing [13] and have
been used to evaluate interventions designed to remove
senescent cells [14–16]. Cultures of aged cells are a hetero-
geneous population, consisting of proliferative, senescent,
growth arrested and apoptotic cell populations [17]. Tissues
and organs in older humans are likewise a complex mixture
of senescent, proliferative and growth arrested cell popu-
lations [18]. Determining the trajectory towards replicative
senescence while distinguishing between senescence and
reversible growth arrest is crucial for evaluating the effective-
ness of new approaches to remove or rejuvenate senescent
cells. Commonly used senescence markers are diverse and
with none purely specific for senescence [19] meaning that
accurate quantification of senescent cell numbers in different
tissue types is still a challenge. Combining multiple exper-
imental markers to better understand the transition of a cell
population to replicative senescence is labour intensive and
time consuming. Cells in a mixed population may be in one
of four potential states: proliferating (viable cells growing
through mitosis), senescent (irreversibly growth-arrested),
quiescent (reversibly growth-arrested) or apoptotic (initiating
cell death) [20,21].
The most frequently used marker for cellular senescence
is senescence-associated beta galactosidase (SA-β-Gal) [22],
although others have suggested the combination of the pro-
liferation markers Ki-67 and PCNA, and the DNA damage
marker γH2AX is optimal [23]. The use of single markers
can however be problematic. Ki-67 for example can reliably
detect cells in the G1 phase of the cell cycle, but can also posi-
tively stain cells arrested in G2 [24]. γH2AX will identify any
DNA damage, not only that associated with senescence. Con-
current measurements of multiple markers throughout the
replicative span therefore provide a more complete picture
of the trajectory towards replicative senescence but require
integration to properly interpret the proportion of cells in
each of these four states during the course of senescence.
There is a need for a deeper theoretical understanding
(through a systems biology approach using computational
biology) of the trajectory of replicative cell populations.
A systems biology approach can be used to bring together
biological knowledge, experimental evidence and sets of
assumptions to simulate the replicative life-course of cell
populations. Others have used dynamical systems modelling
to model the proliferating and senescent populations using
differential equations and were able to reproduce some of
the characteristics of experimental markers such as popu-
lation doublings and SA-β-Gal (similarly SAHF) but not of
other markers such as γH2AX and Ki-67 [23]. Although
promising, this approach has not been fully exploited for
investigating cellular senescence.
We present here a dynamical systems model that captures
the dynamics of four senescence markers (SA-β-Gal, Ki-67,
γH2AX and TUNEL) over 16 passages in human primary
fibroblasts to assess the trajectories of proliferating (P), senes-
cent (S), growth-arrested (G) and apoptotic (A) cells over the
replicative life-course. The model incorporates growth-
arrested and apoptotic populations while also tracking the
doubling age of proliferating cells. Parameters in the model
control the rates at which cells transition between these differ-
ent states (see schematic diagram of possible transitions infigure 1a). The doubling age of proliferating cells is modelled
allowing for these rates to depend on cell doubling age
(figure 1b). Genetic parameter optimization methods are
used to set the model’s minimal set of parameters for the
model outputs to best match the recorded experimental mar-
kers. Once fitted to experimental data, the model
simultaneously captures the dynamics features of all five
experimental markers and, importantly, reproduces the pro-
portion of cells in each state over the replicative time-course.
Moving beyond the state of the art, our work demon-
strates that a simple set of rules governing transitions
between cell subtypes can, when implemented in a dynami-
cal model, capture the dynamics of cell proliferation over the
replicative life-course. The model description is minimal,
designed with a core set of parameters that are well con-
strained by our experimental data. To illustrate the model’s
utility in supporting experiments on senescence, an optimal
strategy for the sparse collection of data is presented.
Our model provides a full account of the proportion of
cells in each of four different states (proliferating, senescent,
growth-arrested and apoptotic) and predicts the convergence
of these proportions beyond the end of the experiment. It pro-
vides a valuable tool for measuring senescence and,
therefore, for evaluating approaches to modify or reverse
cellular ageing.2. Methodology
2.1. Experiments on human primary fibroblasts
Human primary dermal fibroblast (nHDF) cultures were used
in this study. Standard culture conditions were a seeding den-
sity of 6 × 104 cells cm−2 in media (C-23020, Promocell,
Heidelberg, Germany) containing 1% penicillin and streptomy-
cin, and a fibroblast-specific supplement mix consisting of fetal
calf serum (3% v/v), recombinant fibroblast growth factor
(1 ng ml−1) and recombinant human insulin (5 µg ml−1) (Promo-
cell, Heidelberg, Germany). Cells were counted, and equal
numbers of cells seeded in 25 cm2 flasks at each passage in con-
tinuous culture. Cells were maintained at 37°C and 5% CO2 and
senescence markers were measured in triplicate in each passage
from p5 to p20. The biochemical senescence marker SA-β-Gal
was assessed using a commercial kit (Sigma Aldrich, UK)
according to manufacturer’s instructions. Terminal DNA break-
points in situ 3-hydroxy end labelling (TUNEL) was used to
quantify levels of apoptosis. The TUNEL assay was performed
with Click-iT® TUNEL Alexa Fluor® 488 Imaging Assay kit
(Thermofisher, UK) following the manufacturer’s instructions.
Negative and positive controls were also performed. Cells
were double stained for proliferation rate and DNA damage
markers; Ki-67 and γH2AX were used respectively. Cells were
fixed for 10 min with 4% PFA and permeabilized with 0.025%
Triton and 10% serum in PBS for 1 h. Cells were then incubated
with a rabbit monoclonal anti-Ki-67 antibody (ab16667, Abcam,
UK) at 1 : 250 and a mouse monoclonal anti-γH2AX (ab26350,
Abcam, UK) at 1 : 500 overnight at 4°C followed by FITC-conju-
gated secondary goat anti-rabbit (ab16667) and anti-mouse
(ab150117) at 1 : 200 for 1 h, and nuclei were counterstained
with DAPI.
2.2. Dynamics systems model to reconstruct the
senescence time-course
The model captures the unconstrained growth of a cellular popu-
lation during its transition from an exponential growth phase to a
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Figure 1. (a) Schematic for dynamical systems model of transition to senescence. Each proliferative state is represented by a population Pi with doubling age i (to a
maximum age i = N, the Hayflick limit). The transition of one cell from a population Pi results in two cells entering the next population Piþ1. At any doubling age, a
cell can jump to the senescent population S as a result of levels of DNA damage or other cellular stressor. Cells can also transition into the arrested G and apoptotic A
states. (b) Optimized transition parameters. The transition rates from proliferative cells into other states are assumed to have linear dependence on doubling age.
Linear relationships (slope and intercept) were determined through optimization against five markers (doubling population, SA-β-gal, Ki-67, γH2AX and TUNEL; see
figure 3). The proliferation rates decrease with cell doubling age, reflecting the slowing of movement through the cell cycle as the doubling age increases. The rates
of transition into senescence, arrest and apoptosis all increase with doubling age. The increasing rate of transition into senescence and apoptosis reflects the
increased probability of these transitions due to factors such as DNA damage, telomere shortening and double-stranded breaks. The increasing rate of transition
into quiescence reflects the effect of, for example, signalling from senescent cells.
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3senescent state (no longer dividing), which happens between
passage 5 (PD5) and passage 20 (PD22) in our experimental
dataset. Individual cells within the model are classified as
belonging to either a proliferative (P), growth-arrested (G),
apoptotic (A) or senescent (S) population; see the schematic dia-
gram in figure 1a. Cells within the proliferative population are
further divided into proliferative subpopulations with respect
to the number of times they are predicted to have divided.
The subpopulation Pi consists of cells that have divided i
times. We call the index i the doubling age of the subpopulation
(capturing e.g. the gradual degradation of telomeres following
sequential cell division). Tracking doubling age in this way
allows for the rates of transitions into other states to depend
on it. There is a total of N proliferative populations, where N
is maximum number of times a cell can divide prior to reaching
the senescence state. Here, modelling nHDFs, we chose N = 50
and found that our results were not sensitive to this choice
(discussed further below).
2.3. Transitions between cellular populations
The proportion of cells in each population varies over time as
captured by a system of coupled differential equations. These
equations describe the transition of cells between cellular popu-
lations over time. A full description of the equations is given in
electronic supplementary material, while a summary of the
assumptions used to define the equations is given here. We
assume that at the beginning of the experiment the initial popu-
lation of seed cells reside in the P0 subpopulation. The transition
from one proliferative subpopulation to the next captures mitosis
and so cells enter Piþ1 at twice the rate that they leave Pi (shown
as horizontal arrows in figure 1a). Cells can reach the subpopu-
lation S by two mechanisms, the first of which is division.
Since cells can transition to senescence by division of the popu-
lation PN1, we sometimes use PN to denote the senescent
population S (figure 1a). Cells can also enter the senescent popu-
lation directly from any proliferative population, with a rate that
increases with doubling age (top grey arrows). This mimics a
direct accrual of DNA damage, independent of cell division,
which is sufficient to halt cellular proliferation. Thus, cells ‘jump-
ing’ from proliferative to senescence enter the senescent
population at the same rate they leave Pi. Likewise, cells fromall proliferative populations can enter growth-arrested and
apoptotic cellular populations at the same rate they leave Pi
(arrows down to G and A). An example equation describing
the rate of change of proliferative population Pi per unit time is
dPi
dt
¼ 2mPi1PiPi1  ðmPiPiþ1 þ mPiS þmPiA þmPiGÞPi,
where the left of the equation expresses the rate of change of the
number of cells in Pi, which is proportional to the right side of
the equation. In this equation the number of cells entering Pi is
proportional to Pi1 and the number of cells leaving is proportional
to Pi. The rates described above are m, with a subscript for
each population or subpopulation involved in a given transition;
e.g. mPiS is the rate of transition from the proliferating subpopu-
lation Pi to the senescent population S. Similar equations
describe the rate of change of the number of cells for each
proliferating subpopulation Pi and each population G, A and S.
The system of equations can be solved over time (a simu-
lation) to produce trajectories for the number of cells in each
population, which can be compared to our experimental data.
The rates m are assumed to depend linearly on the doubling
age of the proliferating cells. These linear dependencies
(figure 1b) are determined through an optimization routine as
described below. The model parameters that determined the
rates m are listed in table 1.
The relationships between the model outputs and our exper-
imental markers need to be defined in order to make a direct
comparison. As our model continuously monitors the number
of cells in each population, comparing the population doublings
in the model to those measured experimentally is straightfor-
ward. For both we used the formula
PD(tÞ ¼ log2
TPðtÞ
TP(0Þ ,
where PD is the total number of population doublings and TP is
the total population. In the model TP = P +G + S +A.
The output from the model’s differential equations is the pro-
portion of cells in each population P, G, A and S. In order to
compare these with our experimental markers it was necessary
to define relationships between the proportion of cells in each
population and the proportion of cells of each type expressing
Table 1. N = 50 is the maximum number of times a cell in the population can divide (analogous to Hayflick number). The choice of N-value had only a
minimal effect on the data fit (see electronic supplementary material). The transition rate parameters mGS and mAD are positive numbers determined through
optimization (2 of 14 free parameters). The transition rate parameters mPiPiþ1 , mPiS , mPiG , mPiA are lists of N values with a linear relationship to N as set by
the positive-valued endpoints mP0X and mPN1X determined by optimization (8 of 14 parameters). The fraction of contribution from each population (P or G) to
each marker (γH2AX or Ki-67) is set by PgH2AX , GKi67, GgH2AX , which take values between 0 and 1, determined by optimization (3 of 14 free parameters).
These contributions are not known but form part of the optimization cost function (rather than part of the dynamical system).
parameters mP0P1 mPN1PN mP0G mPN1G mP0S mPN1S mP0A mPN1A mGS mAD
rates (h−1) 0.0259 0.0063 0.0018 0.0037 0.0026 0.0053 0.0018 0.0016 0.0007 0.0010
parameters PgH2AX GKi67 GgH2AX
proportions 0.2385 0.9979 0.8237
parameters N
value 50
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4the markers SA-β-Gal, Ki-67, γH2AX and TUNEL as measured in
the experiments. It is assumed that SA-β-Gal and TUNEL map
directly onto senescent (SA-β-Gal) and apoptotic (TUNEL) popu-
lations. However, faithfully accounting for positive Ki-67 or
γH2AX staining in our model is more complex. There is evidence
that Ki-67 is identifiable not only in proliferating cells, but also in
a proportion of cells which are growth-arrested [25]. As such, as
well as the proliferative population, Ki-67 also maps onto a frac-
tion of the growth-arrested population within our model.
Likewise the expression of γH2AX was assumed to be pro-
portional to the entire senescent, entire apoptotic and fractions
of the growth-arrested and proliferative populations (in part
based on the observations that around 30% of cells expressed
γH2AX at passage 5, when cells are predominantly proliferative,
and close to 100% of cells expressed γH2AX at passage 20 when
cells are predominantly a mix of senescent and growth-arrested)
[26]. In each case the fractions were determined through
optimization.
The model was fitted to the experimental dataset using a
genetic algorithm in the MATLAB programming environment.
A cost function was defined as the total difference between the
experimentally recorded markers and those predicted by the
model, as dependent on a set of 14 model parameters (table 1).
A gradient descent routine was also used to further refine the
optimization and verify that a local minimum of the cost function
had been found. For full details of the optimization of the model
refer to the electronic supplementary material.3. Results
The following senescence markers were used in this study
[27]: SA-β-Gal activity (typical enzymatic activity for senes-
cent cells), Ki-67 staining (commonly used in the detection
of proliferating cells), γH2AX assay (a marker of DNA
damage) and TUNEL (detects apoptotic DNA fragmenta-
tion); see figure 2. We also assessed the population
doublings (PD) to measure cell growth kinetics. The exper-
imental results provide a percentage of cells expressing
each marker, which can be compared with our model that
tracks the proportion of cells in different states. While each
marker is related to the proportion of senescent cells in
the cell population they map to other cellular states includ-
ing proliferating, growth arrested and apoptotic. The
contribution of each distinct cellular population within our
model (P, G, S and A) to each experimental marker was
defined (see Methodology for details), allowing directcomparison of experimental and model cellular populations
along the trajectory towards senescence. The experimental
data were then used to constrain the model we develop
via parameter optimization.3.1. Model accurately captures five experimental
markers
Our results agree with the trajectory for these markers
reported in previous studies [28]; see figure 3a–e. By passage
20 (PD22) (around 2500 h of cultivation) the cell population
growth has plateaued; see figure 3a where the last two
points have similar values. The expression of SA-β-Gal
increases steadily over time reflecting the larger proportion
of senescent cells as the population ages; see figure 3b.
There is a similar regular increase for γH2AX primarily due
to the accrual of DNA damage; compare figures 3b and 3d.
The proportion of proliferative cells decreases with time as
reflected by the consistent decreases of Ki-67; see figure 3c.
The proportion of apoptotic cells at the end of each passage
remains relatively steady throughout the experiment as
reflected by the TUNEL measurements in figure 3e. This data-
set of 16 time points across five makers provides ample data
to constrain the model’s 10 free parameters.
Following parameter optimization, the model (grey
curves) was able to simultaneously capture the features of
all the trajectories of all five markers (black points) from the
experimental dataset; see figure 3a–e. The model’s dynamic
variables directly capture the proportion of cells in each
state, thus revealing the trajectories of each population over
the senescence time course; figure 3f. Note that the model’s
representation of each marker in figure 3b–e (grey curves) is
assumed to be proportional to one or more of the populations
P, S, G and Awith constant scaling factors as indicated in the
panel titles.
The trajectories of the different cell populations shown
in figure 3f show that for early passages (approximately
time 100–2500), the proportion of proliferating cells (P)
decreases linearly, while the proportion of senescent cells S
increases linearly. After 2500 h these trajectories start to pla-
teau towards a minimal value for P and a maximal value
for S. Here the model allows us to extrapolate the trajectories
beyond the end of the experiment where, given the minimal
growth rate, it would be very time consuming to collect
p5
Ki-67
gH2AX
TUNEL
SA-b-Gal
p10 p15 p20
Figure 2. Sample images used for quantification of experimental markers of senescence in human dermal fibroblasts from an early passage (p5) to senescence
( p20). For of Ki-67, γH2AX and TUNEL a blue fluorescing DAPI marker binding to DNA is expressed in all cells and an additional colour is expressed if the cell is
positive for the given marker. In general the total number of cells decreases with time (note fewer cells at p15 and p20). For SA-β-Gal, cells expressing the marker
are determined with a cytochemical assay that stains blue, while total cell counts are determined with high contrast images (not shown). Over time the proportion
( percentage of total) cells expressing Ki-67 decreases ( pink), γH2AX increases (light blue), TUNEL increases (green) and SA-β-Gal increases (blue). The markers were
quantified by microscopy (using many images similar to those shown here), calculating the percentage of stained positive with a minimum of 300 cells assessed per
replicate. Each marker was assessed in three biological samples per passage with two technical replicates. An automated haemocytometer was used for cell counts in
order to compute population doublings (not shown). (Online version in colour.)
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5further data. The model also predicts a peak in the proportion
of growth-arrested cells at around 2200 h; see Discussion.3.2. Analysis of experimental strategies for efficiently
measuring senescence time-course
The experimental dataset collected for this study consisted of
five markers spanning the replicative life-course at 16 time-
points from passage 5 to 20 (80 measurements total). This
time-intensive approach provides a detailed description
of the dynamics of each marker. Here we illustrate how the
correct strategy for reducing the required number of measure-
ments can be used in conjunction with the dynamical systems
model to efficiently reproduce the trajectory of the markers
and of the populations (P, S, G, A).
Figure 4 shows, taking the full set of 80 measurements
(5 markers, 16 points) as the baseline, how much error is
introduced by removing different numbers of measurements
of all the markers. The error is computed as percentage
increase in the optimization cost function relative to the base-
line value (see Methodology); one can think this increase in
error as a proxy for the amount of information lost by not
making measurements at different stages of the experiment.
Different strategies can be employed: not measuring early
passages (figure 4a), not measuring the late passages
(figure 4b), not measuring intermediate passages (figure 4c)
or not measuring a set of points from the middle of the exper-
iment (figure 4d ). If 1–2 points are removed from the data,
irrespective of when during the experiment, this has little
impact on the error (see figure 4a,b,d ). However, once more
than 4 points are removed the strategy is important, withdata from the final passages being more valuable (compare
figure 4b with 4a and figure 4d). The best strategy is to
remove intermittent points, i.e. to take regularly spaced
measurements over the course of the entire experiment (com-
pare figure 4c with other panels). These results show that
skipping 2/3 measurements (‘skip 2’) introduces around 10%
error while reducing the number of measurements from 80
to 30 (10 measurements skipped for each of the five markers).
Our results demonstrate an optimal strategy for reducing
the number of experimental measurements taken. Taking
equally spaced measurements throughout proved to be a
good strategy to minimize the effective loss of information,
rather than omitting measurements at the beginning, end or
consecutively in the middle of an experiment. The worst strat-
egy proved to be omitting measurements at the end of the
experiment, even though in practical terms these may take
the longest to obtain as the growth rate slows. Notably, exper-
imental strategies predicted by the model assume that an
initial seed population (consisting entirely of proliferative
cells) is allowed to transition to senescence uninterrupted.
For example, in its current form, this model cannot account
for the substantial metabolic and biochemical alterations
likely to occur following freeze–thaw.
3.3. Model optimization sensitivity analysis
A sensitivity analysis was performed to assess the relative
importance of different parameters for the model optimiz-
ation. Figure 5a,b illustrates the relative increase in error
(relative to the optimized solution, a black dot in each
panel) for changes to model parameters controlling the
rates of the transitions between different states, as depicted
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Figure 3. Optimized model trajectories versus markers. Experimental data points for human primary fibroblast cells recorded from passage 5 (PD5) to passage
20 (PD22) plotted with time in hours: PD (a), SA-β-Gal (b), Ki-67 (c), γH2AX (d ), and TUNEL (e). The best fit trajectories from the dynamical systems model are
plotted as grey lines. In the case of Ki-67 (c), where some unknown proportion of growth-arrested cells are represented, we include the proportion given by the
optimizer in the panel title. Likewise, in the case of γH2AX (d ), where an unknown proportion of growth-arrested and proliferative cells is represented, we include
the proportion given by the optimizer. Panel ( f ) shows the complete senescence time-course for each population over 5000 h. As expected, the proportion of pro-
liferative cells starts near 100% and decreases to 0% over the length of the experiment. At the end of the experiment, only senescent and growth-arrested cells remain.
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6by arrows in figure 1a. Where these rates were assumed to
depend on doubling age, a two-dimensional plot shows
the initial rate at P0 versus the final rate at PN1 with the
change in error as a greyscale map; see figure 5a. For the
rate of transitions between proliferating populations, a
decreasing relationship was optimal (i.e. the growth rate
slows with doubling age). Note there would be a significant
(around 50%) increase in the error if this relationship were
assumed flat (along the dashed white line). For the rates of
transition from proliferating to growth-arrested and from
proliferating to senescent, the best-fit solutions corresponded
to increasing relationships with doubling age (see slopes in
figure 1a); however, there would not be a dramatic increase
in error if these were considered constant, i.e. took values
along the diagonal. For the rate of transition from prolifera-
tive to apoptotic the best-fit solution corresponded to a flat
relationship (no change with doubling age) and the error
would increase rapidly if this were not the case. Figure 5bshows that the error would increase quite rapidly if the
rates of transition from grow-arrested to senescent were to
increase. However, if the rate of growth-arrested to senescent
was to be reduced to 0, this would not result in a particularly
large increase in error, suggesting a possible simplification to
the model.
A further analysis using the holdout methodwas performed
to assess the effect on the additional error introduced when
omitting some experimental data from the optimization (see
electronic supplementary material for full details). Overall
we found a small (2%) increase in the total error introduced
when removing around 20% of the data points before optim-
ization. Furthermore, statistical tests to see whether fixing any
single parameter during optimization reduced the error intro-
duced by holding out data did not reach significance. These
results suggest that the original optimization approach effec-
tively found a global minimum and that redundancy for the
parameters used for optimization is low.
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Figure 4. Analysis of strategies for reconstructing the senescence time-course using fewer recordings. (a–d) Each row illustrates a different strategy for collecting less
data. Left panels show relative increase in error when trajectories are constructed as in figure 1 but using fewer data points in the parameter optimization. The
baseline is the cost function error if all data points are included. Right panels show an example of the fit for SA-β-Gal when quoted number of points are removed
(open circles show omitted points). (a) Removing data points at the beginning of the experiment quickly has a large effect on the overall error. Note that while
SA-β-Gal may be still reasonably well tracked by the model output, the fit for other markers is worse (data not shown). (b) Removing data points from the end of
the experiment has a dramatic effect when more than four passages are omitted. (c) Removing intermediate data points has a relatively small effect on the error
introduced. (d ) Removing intermediate blocks of points has a relatively small effect on the error introduced but there is a dramatic increase for more than 6 points.
royalsocietypublishing.org/journal/rsif
J.R.Soc.Interface
16:20190311
7The final three parameters shown in figure 5c determine
the proportion of cells in each population that contribute
towards the model’s representation of γH2AX and Ki-67.
Rather than setting arbitrary values for these proportions,
they were left as free parameters in the optimization (as
there is little available evidence to fix them). Importantly,
this sensitivity analysis shows that effectiveness of the optim-
ization only depends weakly on these parameters; see
Discussion as to whether these values might generalize
across cell models.4. Discussion
We present here the first model capable of combining
multiple experimental markers to reproduce the complete
time-course of a cell population ageing towards replicative
senescence. The model provides a full account of the pro-
portion of cells in each of four different states (proliferating,
senescent, growth-arrested and apoptotic) and predicts the
convergence of these proportions beyond the end of the
experiment. The close match to our experimental data was
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8found to be robust with respect to small changes in parameter
values. The model description is parsimonious, defined in
terms of a minimal set of parameters that are well constrained
by the experimental data. Our investigation of different strat-
egies for collecting data more sparsely shows that similar
results could be attained by collecting as few as 30 measure-
ments (taking sparse measurements, equally spaced by
passage). Indeed, the model could provide a good means to
predict when to stop making measurements, thus allowing
for better planning of commitments to bench time. The mod-
elling framework has great potential as a tool for the
senescence and ageing research communities.
Various modelling approaches have been used to investi-
gate senescence. Lawless et al. [29] modelled proliferating
and senescent populations using differential equations
(a dynamical system) and were able to reproduce some of the
characteristics of experimentalmarkers such as population dou-
blings and SA-β-Gal (similarly SAHF) but not of other markers
such as γH2AX and Ki-67. The dynamical systems modelpresented here can be viewed as a significant advance on the
earlier model presented in [29]. Notably, the model presented
here includes the doubling age of the proliferating populations
(see distinct P populations in figure 1a). This allows for the rates
of transition from the proliferating population to depend on
doubling age (figure 1b). Further, by considering not only the
senescent and proliferating population, as in [29], but also the
growth-arrested and apoptotic populations, we were able to
give a complete picture of the dynamics and to obtain a good
match between model outputs and all the markers recorded.
Multiple proliferative populations have been considered in
models geared towards studying haematopoietic stem cells
[30] and cancer [31,32]. Spatial interactions in two dimensions
have also been considered in tumour models [33], a significant
increase in complexity relative to the approach used here. In the
present study the dynamics of the growing cell population and
the transitions from proliferation were assumed to be determi-
nistic at the level of the entire population. Other studies have
considered probabilistic descriptions of the transitions between
royalsocietypublishing.org/journal/rsif
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9cell states [34] as influenced by cell signalling factors. A stochas-
tic model has been used to explore observed increases in
reactive oxygen species concentration with age [35]. Another
model was defined at a more granular level—investigating
gene signalling networks [36]; however, the model has over 60
parameters and 14 state variables, meaning that it is unlikely
that the model is meaningfully constrained by available exper-
imental data.
The structure of the model presented is general and,
although used here to fit data from a monolayer human pri-
mary fibroblast culture, it could fit data from other cell types
using similar markers that provide sufficient information
about each cell subtype (proliferating, senescent, growth-
arrested and apoptotic) with little modification. Differences
between an artificial experimental system and in vivo
measurements could be explored in further studies. Vali-
dation of the approach with other cell types remains to be
done and this would be a necessary step to demonstrate the
generalizability of the framework. Incorporating different
markers for use with the model requires that the relative con-
tribution of each population to the marker be proposed. As
was done in this study for γH2AX and Ki-67, some of these
contributions could be left unspecified (left as free parameters
in this study, these contributions did not have a strong bear-
ing on the accuracy of the model fit to data; figure 5).
Furthermore, while there may be significant differences
across cell types in terms of the strength of the paracrine
‘bystander’ effect induced by SASP which may influence the
point at which a culture becomes static [37], the modelling fra-
mework presented here is adaptable to take these differences
into account. The use of a similar model and marker set in
different cell types could allow establishment of which par-
ameters are cell-type dependent and which remain fixed. In
the light of these findings, it may be possible to use fewer mar-
kers to constrain the model and accurately reproduce the
senescence time-course. We note that the number of cells
entering apoptosis in each passage appears to be consistently
around 5–10% here and in our previous experimental work
[14]. Furthermore the model could help characterize these
differences across cell types in terms of biologically meaning-
ful parameters. A distinction between senescent and growth
arrest [21] is necessary to account for the markers measured
in our experiments. While making a distinction between senes-
cent and growth-arrested cells in the model, it was assumed
that the reversal of growth arrest back into a proliferative
state was not significant. The assumption is based on the
observation that factors (SASP released from senescent cells)
inducing growth arrest cannot recede in the experiments per-
formed here. We note that a peak in the number of growth-
arrested cells is predicted by the model, its presence being reli-
ant on the presence of transitions from growth-arrested to
senescent as proposed in [38]. The effect of removingtransitions from growth-arrested to senescent is discussed in
the electronic supplementary material, figure S1. Transitions
from growth arrest to apoptotic were not considered as these
cells would not be going through the cell cycle [39]. Additional
analysis showed that changing the rate of transitions to the
apoptotic and growth-arrested populations had a much smal-
ler effect on the time to reach 85% senescence in comparison
with changing the proliferation rate or rate of transitions to
senescence (see electronic supplementary material, figure S2).
A significant simplification of the present model is that no dis-
tinction is made between different stages of the cell cycle and
that growth-arrest or senescence can occur in different ways
[40]. Cells arrested in G1 would be predicted to stain positively
for SA-β-Gal and γH2AX, but not for Ki-67, whereas cells in
G2 would stain positively for all three markers.
A dynamical systems approach has proven an effective
strategy for modelling the proliferation and progression
towards senescence of cultured cells. The presented model
goes beyond previous studies in being able to capture the tra-
jectory of multiple markers simultaneously while giving a
complete account of the cell population’s different subtypes.
The potential to generalize the adaptable framework pre-
sented should be tested in future work using data collected
from other cell types and markers. An extension to consider
further information through the cell cycle—only mitosis
was considered here—would allow for a more detailed link
to experimental markers. Here we provide a new approach
to the study of ageing, developing a dynamical systems
model that offers a complete accurate description of the
dynamics of the transition to cellular senescence at the popu-
lation level. Our model highlights the utility of predictive
mathematical modelling in better understanding the factors
of cellular senescence and the ageing process itself.
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